Cargando…
Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection
Zika virus (ZIKV) is an emerging pathogen associated with neurological complications, such as Guillain-Barré syndrome in adults and microcephaly in fetuses and newborns. This mosquito-borne flavivirus causes important social and sanitary problems owing to its rapid dissemination. However, the develo...
Autores principales: | Song, Weibao, Zhang, Hongjuan, Zhang, Yu, Li, Rui, Han, Yanxing, Lin, Yuan, Jiang, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768800/ https://www.ncbi.nlm.nih.gov/pubmed/33369711 http://dx.doi.org/10.1007/s11684-021-0834-9 |
Ejemplares similares
-
Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors
por: Song, Weibao, et al.
Publicado: (2021) -
Repurposing of drugs against methyltransferase as potential Zika virus therapies
por: Shukla, Rohit, et al.
Publicado: (2023) -
Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019) -
Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy
por: Tan, Li Yin, et al.
Publicado: (2022) -
Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays
por: Chen, Ying, et al.
Publicado: (2023)